Skip to content

Clinical Study on the Safety and Efficacy of Thermage Therapy Combined with Replasty Series Products on the Skin

Exploratory clinical study evaluating of the benefit of repeated applications of a Replasty beauty routine in addition to a thermage session

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300078845
Enrollment
Unknown
Registered
2023-12-19
Start date
2023-12-21
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anti aging and soothing

Interventions

Experimental group:Thermage Treatment and Use Test Products
Control group:Thermage Treatment and Use Control Products

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
45 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Healthy Asian women: 2.Aged > 45, 3.Who have not exposed themselves to the sun or UV within 2 weeks prior to the study and not planned to expose themselves intensively to the sun or UV during the study 4.Who present on both sides of the face ptosis of the lower face (score = 1 from Asian Atlas [1] p67) 5.Who present on both sides of the face a lack of firmness (score = 3 and = 6 from a 10-grade scale) 6.Who present on both sides of the face crow’s feet wrinkles (score = 2 from Asian Atlas [1] p41) 7.Who present on both sides of the eye drooping of the upper outer eyelid (score = 2 from Asian Atlas [1] p43) 8.Who intended to receive Thermage treatment on their whole face 9.Agreeing to not use another eyecare or skincare product during the trial 10.Who keep the same cleansing habits (product and frequency) during the whole study 11.Who stop using any skincare product on their face 24 hours before the first assessment 12.Informed about the study objectives and procedures, and able to understand them 13.Willing and able to fulfill the study requirements and schedule 14.Who sign an informed consent

Exclusion criteria

Exclusion criteria: 1.Pregnant or wishing to be pregnant during the study or nursing or without effective contraception 2.With any skin or systemic disease (acute and/or chronic), (hyperthyroidism, psoriasis, eczema, acne, diabetes, allergic rhinitis…) and/or with any topical or general treatment likely to interfere with the measured parameters in the opinion of the investigator 3.Who have received any esthetical or dermatological or surgical procedure possibly interfering with the study on the investigation area (thermage, chemical peel, fillers, injection, lifting, …) or who have scheduled such a treatment during the study 4.With any history of allergy to one of the ingredients of the investigational products 5.Who have applied any anti-aging product within 2 weeks prior to the first assessment visit 6.Who have applied skincare products to their face such as: exfoliating, self-tanning, whitening products, mask…within two weeks prior to the beginning of the study 7.Who have scheduled any type of surgery during the study 8.Participation in another clinical trial or volunteers being in the exclusion phase of such a trial, thus being unable to participate in any other one. 9.Who have forfeited their freedom by judiciary decision or are deemed legally incompetent. 10.Unable to comply with the protocol constraints 11.Unable to be contacted by phone in case of emergency 12.With Metal implants in the body

Design outcomes

Primary

MeasureTime frame
Lower sagging;crow's feet;Safety assessment;Skin firmness;Upper and outer eyelid ptosis;

Secondary

MeasureTime frame
Skin stratum corneum moisture content;Skin Temperature;

Countries

China

Contacts

Public ContactLi Li

West China Hospital, Sichuan University

hxskincosm@qq.com+86 28 8542 2075

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026